Matthew Reynolds to Angioplasty, Balloon, Coronary
This is a "connection" page, showing publications Matthew Reynolds has written about Angioplasty, Balloon, Coronary.
Connection Strength
0.785
-
Resnic FS, Arora N, Matheny M, Reynolds MR. A cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary intervention. Am J Cardiol. 2007 Mar 15; 99(6):766-70.
Score: 0.247
-
Reynolds MR, Neil N, Ho KK, Berezin R, Cosgrove RS, Lager RA, Sirois C, Johnson RG, Cohen DJ. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience. Am Heart J. 2003 Feb; 145(2):334-42.
Score: 0.187
-
Reynolds MR, Rinaldi MJ, Pinto DS, Cohen DJ. Current clinical characteristics and economic impact of subacute stent thrombosis. J Invasive Cardiol. 2002 Jul; 14(7):364-8.
Score: 0.180
-
Amin AP, Reynolds MR, Lei Y, Magnuson EA, Vilain K, Durtschi AJ, Simonton CA, Stone GW, Cohen DJ. Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial). Am J Cardiol. 2012 Sep 15; 110(6):765-70.
Score: 0.089
-
Reynolds MR, Pinto DS, Shi C, Walczak J, Berezin R, Holmes DR, Cohen DJ. Cost-effectiveness of sirolimus-eluting stents compared with vascular brachytherapy for the treatment of in-stent restenosis. Am Heart J. 2007 Dec; 154(6):1221-7.
Score: 0.064
-
Pinto DS, Stone GW, Shi C, Dunn ES, Reynolds MR, York M, Walczak J, Berezin RH, Mehran R, McLaurin BT, Cox DA, Ohman EM, Lincoff AM, Cohen DJ. Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. J Am Coll Cardiol. 2008 Nov 25; 52(22):1758-68.
Score: 0.018